Manlosa, Eddie A.
HRN: 28-38-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2026
ACICLOVIR 800MG (TAB)
01/07/2026
01/17/2026
PO
800mg
Q12H
Herpes Zoster Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes